Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Translational Science

Business & Regulation Drug Delivery

What's New from The Cell + Gene Curator?

| James Strachan

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

Manufacture Analytical Science

Nominations for the 2021 Innovation Awards

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

Discovery & Development Advanced Medicine

Understanding the Three Levels of Genetic Medicine

| James Strachan

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Discovery & Development Advanced Medicine

Don’t Break My Strands

| Emily M. Anderson

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.

Business & Regulation Advanced Medicine

Video Roundtable: What can Advanced Medicine Learn from COVID-19?

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

Business & Regulation Advanced Medicine

The 2021 Power List is Out

We reveal The Medicine Maker 2021 Power List!

Discovery & Development Translational Science

A Center for Space Medicine

| Stephanie Sutton

We find out the story behind the Baylor College of Medicine Center for Space Medicine.

Manufacture Bioprocessing - Upstream & Downstream

Combating COVID-19

| Daria Donati

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

Discovery & Development Vaccines

Beyond the Storm

| Stephanie Sutton

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

Manufacture Bioprocessing - Upstream & Downstream

A Grueling Environment

| Phil Williams

NASA ultimately wants to send humans to Mars – and those humans will need medicines.


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register